Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes

Lin Xu, Yanbin Zheng, Jing Liu, Dinesh Rakheja, Sydney Singleterry, Theodore W Laetsch, Jack F. Shern, Javed Khan, Timothy J. Triche, Douglas S. Hawkins, James F Amatruda, Stephen X Skapek

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Identifying oncogenic drivers and tumor suppressors remains a challenge in many forms of cancer, including rhabdomyosarcoma. Anticipating gene expression alterations resulting from DNA copy-number variants to be particularly important, we developed a computational and experimental strategy incorporating a Bayesian algorithm and CRISPR/Cas9 “mini-pool” screen that enables both genome-scale assessment of disease genes and functional validation. The algorithm, called iExCN, identified 29 rhabdomyosarcoma drivers and suppressors enriched for cell-cycle and nucleic-acid-binding activities. Functional studies showed that many iExCN genes represent rhabdomyosarcoma line-specific or shared vulnerabilities. Complementary experiments addressed modes of action and demonstrated coordinated repression of multiple iExCN genes during skeletal muscle differentiation. Analysis of two separate cohorts revealed that the number of iExCN genes harboring copy-number alterations correlates with survival. Our findings highlight rhabdomyosarcoma as a cancer in which multiple drivers influence disease biology and demonstrate a generalizable capacity for iExCN to unmask disease genes in cancer.

Original languageEnglish (US)
Pages (from-to)238-251
Number of pages14
JournalCell Reports
Volume24
Issue number1
DOIs
StatePublished - Jul 3 2018

Fingerprint

Bayes Theorem
Rhabdomyosarcoma
Genes
Clustered Regularly Interspaced Short Palindromic Repeats
DNA Copy Number Variations
Neoplasms
Gene Dosage
Neoplasm Genes
Nucleic Acids
Cell Cycle
Skeletal Muscle
Genome
Gene Expression
Gene expression
Muscle
Tumors
Cells
DNA
Experiments

Keywords

  • Bayesian algorithm
  • childhood cancer
  • CRISPR/Cas9
  • integrative genomic analysis
  • oncogene
  • rhabdomyosarcoma
  • tumor suppressor gene

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes. / Xu, Lin; Zheng, Yanbin; Liu, Jing; Rakheja, Dinesh; Singleterry, Sydney; Laetsch, Theodore W; Shern, Jack F.; Khan, Javed; Triche, Timothy J.; Hawkins, Douglas S.; Amatruda, James F; Skapek, Stephen X.

In: Cell Reports, Vol. 24, No. 1, 03.07.2018, p. 238-251.

Research output: Contribution to journalArticle

Xu, Lin ; Zheng, Yanbin ; Liu, Jing ; Rakheja, Dinesh ; Singleterry, Sydney ; Laetsch, Theodore W ; Shern, Jack F. ; Khan, Javed ; Triche, Timothy J. ; Hawkins, Douglas S. ; Amatruda, James F ; Skapek, Stephen X. / Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes. In: Cell Reports. 2018 ; Vol. 24, No. 1. pp. 238-251.
@article{d7213e465cf9429792c2cd9f883f766a,
title = "Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes",
abstract = "Identifying oncogenic drivers and tumor suppressors remains a challenge in many forms of cancer, including rhabdomyosarcoma. Anticipating gene expression alterations resulting from DNA copy-number variants to be particularly important, we developed a computational and experimental strategy incorporating a Bayesian algorithm and CRISPR/Cas9 “mini-pool” screen that enables both genome-scale assessment of disease genes and functional validation. The algorithm, called iExCN, identified 29 rhabdomyosarcoma drivers and suppressors enriched for cell-cycle and nucleic-acid-binding activities. Functional studies showed that many iExCN genes represent rhabdomyosarcoma line-specific or shared vulnerabilities. Complementary experiments addressed modes of action and demonstrated coordinated repression of multiple iExCN genes during skeletal muscle differentiation. Analysis of two separate cohorts revealed that the number of iExCN genes harboring copy-number alterations correlates with survival. Our findings highlight rhabdomyosarcoma as a cancer in which multiple drivers influence disease biology and demonstrate a generalizable capacity for iExCN to unmask disease genes in cancer.",
keywords = "Bayesian algorithm, childhood cancer, CRISPR/Cas9, integrative genomic analysis, oncogene, rhabdomyosarcoma, tumor suppressor gene",
author = "Lin Xu and Yanbin Zheng and Jing Liu and Dinesh Rakheja and Sydney Singleterry and Laetsch, {Theodore W} and Shern, {Jack F.} and Javed Khan and Triche, {Timothy J.} and Hawkins, {Douglas S.} and Amatruda, {James F} and Skapek, {Stephen X}",
year = "2018",
month = "7",
day = "3",
doi = "10.1016/j.celrep.2018.06.006",
language = "English (US)",
volume = "24",
pages = "238--251",
journal = "Cell Reports",
issn = "2211-1247",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes

AU - Xu, Lin

AU - Zheng, Yanbin

AU - Liu, Jing

AU - Rakheja, Dinesh

AU - Singleterry, Sydney

AU - Laetsch, Theodore W

AU - Shern, Jack F.

AU - Khan, Javed

AU - Triche, Timothy J.

AU - Hawkins, Douglas S.

AU - Amatruda, James F

AU - Skapek, Stephen X

PY - 2018/7/3

Y1 - 2018/7/3

N2 - Identifying oncogenic drivers and tumor suppressors remains a challenge in many forms of cancer, including rhabdomyosarcoma. Anticipating gene expression alterations resulting from DNA copy-number variants to be particularly important, we developed a computational and experimental strategy incorporating a Bayesian algorithm and CRISPR/Cas9 “mini-pool” screen that enables both genome-scale assessment of disease genes and functional validation. The algorithm, called iExCN, identified 29 rhabdomyosarcoma drivers and suppressors enriched for cell-cycle and nucleic-acid-binding activities. Functional studies showed that many iExCN genes represent rhabdomyosarcoma line-specific or shared vulnerabilities. Complementary experiments addressed modes of action and demonstrated coordinated repression of multiple iExCN genes during skeletal muscle differentiation. Analysis of two separate cohorts revealed that the number of iExCN genes harboring copy-number alterations correlates with survival. Our findings highlight rhabdomyosarcoma as a cancer in which multiple drivers influence disease biology and demonstrate a generalizable capacity for iExCN to unmask disease genes in cancer.

AB - Identifying oncogenic drivers and tumor suppressors remains a challenge in many forms of cancer, including rhabdomyosarcoma. Anticipating gene expression alterations resulting from DNA copy-number variants to be particularly important, we developed a computational and experimental strategy incorporating a Bayesian algorithm and CRISPR/Cas9 “mini-pool” screen that enables both genome-scale assessment of disease genes and functional validation. The algorithm, called iExCN, identified 29 rhabdomyosarcoma drivers and suppressors enriched for cell-cycle and nucleic-acid-binding activities. Functional studies showed that many iExCN genes represent rhabdomyosarcoma line-specific or shared vulnerabilities. Complementary experiments addressed modes of action and demonstrated coordinated repression of multiple iExCN genes during skeletal muscle differentiation. Analysis of two separate cohorts revealed that the number of iExCN genes harboring copy-number alterations correlates with survival. Our findings highlight rhabdomyosarcoma as a cancer in which multiple drivers influence disease biology and demonstrate a generalizable capacity for iExCN to unmask disease genes in cancer.

KW - Bayesian algorithm

KW - childhood cancer

KW - CRISPR/Cas9

KW - integrative genomic analysis

KW - oncogene

KW - rhabdomyosarcoma

KW - tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=85048945051&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048945051&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2018.06.006

DO - 10.1016/j.celrep.2018.06.006

M3 - Article

VL - 24

SP - 238

EP - 251

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 1

ER -